December 18, 2023 11:03 AM ESTUpdated December 19, 08:26 AM

First Wave to merge with ImmunogenX; Caliway raises $100M; New deals for Replay’s Syena

Kyle LaHucik

Senior Reporter

Ayisha Sharma

News Reporter

First Wave BioPharma’s merger plans: The Florida biotech said it plans to merge with ImmunogenX, another gastrointestinal diseases company that is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

First Wave to merge with ImmunogenX; Caliway raises $100M; New deals for Replay’s Syena

Kyle LaHucik

Senior Reporter

Ayisha Sharma

News Reporter

Sign up to read this article for free.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

First Wave to merge with Im­muno­genX; Cali­way rais­es $100M; New deals for Re­play’s Sye­na

Senior Reporter

News Reporter

Sign up to read this article for free.

First Wave to merge with ImmunogenX; Caliway raises $100M; New deals for Replay’s Syena